Columbus Circle Investors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-261,590
Closed -$27.4M 322
2014
Q2
$27.4M Buy
261,590
+75,286
+40% +$7.89M 0.19% 123
2014
Q1
$15.5M Buy
+186,304
New +$15.5M 0.1% 186